Loading organizations...
Developer of biopharmaceutical technologies for protein and vaccine product
Thousand Oaks Biopharmaceuticals has raised $170.6M across 3 funding rounds.
Thousand Oaks Biopharmaceuticals has raised $170.6M in total across 3 funding rounds.
Thousand Oaks Biopharmaceuticals has raised $170.6M in total across 3 funding rounds.
Thousand Oaks Biopharmaceuticals's investors include CDH Investments, CICC Capital, Fosun, Honghui Capital, Jinshi Capital, CITIC Securities, Liefeng Qu, Blue Bay Capital, Ji Lin Ao Dong, Qianrong Holdings, Tenyall & Sumin.
Thousand Oaks Biopharmaceuticals has raised $170.6M across 3 funding rounds. Most recently, it raised $61.4M Series C in March 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 10, 2021 | $61.4M Series C | CDH Investments, CICC Capital, Fosun, Honghui Capital, Jinshi Capital | |
| Jul 24, 2020 | $64.2M Series B | CICC Capital, CITIC Securities | |
| Jan 3, 2019 | $45.0M Series A | Liefeng Qu | Blue Bay Capital, Ji Lin Ao Dong, Qianrong Holdings, Tenyall & Sumin |